PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Adherence to American Cancer Society nutrition and physical activity guidelines among cancer survivors

JAMA Oncology

2024-04-18
(Press-News.org) About The Study: In this cross-sectional study using data from the Behavioral Risk Factor Surveillance System for 10,000 cancer survivors, only 4% of cancer survivors adhered to all four American Cancer Society nutrition and physical activity guidelines, with the mean number of guidelines met being 2.0. Improved understanding of guideline adherence and its determinants may guide oncologists and general internists in providing recommendations for their patients who have completed cancer treatments. 

Authors: Kathryn Norman, M.D., of the Beth Israel Deaconess Medical Center in Boston, is the corresponding author. 

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ 

(doi:10.1001/jamaoncol.2024.0470)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.0470?guestAccessKey=1e2fa0a7-e366-45a2-94c1-969d3f1c82ab&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=041824

 

END


ELSE PRESS RELEASES FROM THIS DATE:

New urine-based test detects high-grade prostate cancer, helping men avoid unnecessary biopsies

2024-04-18
ANN ARBOR, Michigan — Researchers at the University of Michigan Rogel Cancer Center have developed a new urine-based test that addresses a major problem in prostate cancer: how to separate the slow-growing form of the disease unlikely to cause harm from more aggressive cancer that needs immediate treatment.   The test, called MyProstateScore2.0, or MPS2, looks at 18 different genes linked to high-grade prostate cancer. In multiple tests using urine and tissue samples from men with prostate cancer, it successfully identified cancers ...

Researchers reduce bias in pathology AI algorithms using foundation models

2024-04-18
Findings of substantial variability in pathology AI models’ performance based on race, insurance type and age group serve as a “call to action” to researchers and regulators to improve medical equity Large foundation models that incorporate a richer level of detail may mitigate disparities between different demographic groups and enhance model accuracy.   Advanced artificial intelligence (AI) systems have shown promise in revolutionalizing the field of pathology through transforming the detection, diagnosis, and treatment of disease; however, the underrepresentation of certain patient populations in pathology ...

Properties of new materials for microchips can now be measured well

Properties of new materials for microchips can now be measured well
2024-04-18
Making ever smaller and more powerful chips requires new ultrathin materials: 2D materials that are only 1 atom thick, or even just a couple of atoms. Think about graphene or ultra-thin silicon membrane for instance. Scientists at TU Delft have taken an important step in application of these materials: they can now measure important thermal properties of ultrathin silicon membranes. A major advantage of their method is that no physical contact needs to be made with the membrane, so pristine properties can ...

Maltreated children are three times more likely to develop substance use disorders in adulthood

2024-04-18
A new study published in the scientific journal Addiction has found that people who are maltreated as children may be three times more likely to be admitted to hospital for alcohol and substance use disorders by the age of 40, compared with those who are not maltreated. The study used data from over 6,000 children born at the Mater Mothers Hospital, Brisbane, Australia between 1981 and 1983.  Ten percent of those children (609 children) had at least one child maltreatment notification (reported or substantiated) up to 15 years of age. Compared with the rest of the children, those 609 ...

Two U professors selected as AAAS fellows

Two U professors selected as AAAS fellows
2024-04-18
University of Utah Health professors Amy Barrios, PhD, and H. Joseph Yost, PhD, have been elected as Fellows of the American Association for the Advancement of Science (AAAS), a lifetime honor that celebrates their excellence in research and commitment to mentoring the next generation of scientists. Yost and Barrios join a distinguished cadre of AAAS Fellows at the U, including Nancy Songer, PhD; Thure Cerling, PhD; Vahe Bandarian, PhD; Eric W. Schmidt, PhD; Jennifer S. Shumaker-Parry, PhD; and Mario Capecchi, PhD. Rachel Hess, MD, associate vice president for research at U of U Health, says, ...

Dana-Farber Chief Scientific Officer, Kevin Haigis, PhD, elected as Fellow of the American Association for the Advancement of Science

Dana-Farber Chief Scientific Officer, Kevin Haigis, PhD, elected as Fellow of the American Association for the Advancement of Science
2024-04-18
Boston - Kevin Haigis, PhD, Chief Scientific Officer, Dana-Farber Cancer Institute, has been named Fellow of the American Association for the Advancement of Science (AAAS). Election as an AAAS Fellow is a distinguished lifetime honor bestowed upon AAAS members by their peers. Haigis is recognized within Biological Sciences for his distinguished contributions to understanding the complex diversity of cellular dysregulation by different variants of RAS mutations and their consequences in pathophysiology and ...

Siblings with unique genetic change help scientists progress drug search for type 1 diabetes

2024-04-18
Two siblings who have the only known mutations in a key gene anywhere in the world have helped scientists gain new insights that could help progress the search for new treatments in type 1 diabetes. Type 1 diabetes (also known as autoimmune diabetes) is a devastating and life-long disease, in which the patient’s immune cells wrongly destroy the insulin producing beta cells in the pancreas. People living with autoimmune diabetes need to test their blood sugar and inject insulin throughout their lives to control their blood sugars and prevent complications. Autoimmune ...

Four MD Anderson researchers elected AAAS Fellows

Four MD Anderson researchers elected AAAS Fellows
2024-04-18
HOUSTON ― In recognition of their significant achievements in the realm of cancer care and research, four researchers at The University of Texas MD Anderson Cancer Center have been elected fellows of the American Association for the Advancement of Science (AAAS). This prestigious distinction stands as one of the highest accolades within the scientific research community. Boyi Gan, Ph.D., Candelaria Gomez-Manzano, M.D., Li Ma, Ph.D., and Sattva Neelapu, M.D., now join this esteemed group of fellows elected by their peers. AAAS’s annual tradition of recognizing leading scientists as fellows dates to 1874. With these newest additions, 68 MD Anderson faculty members ...

Computational biology pioneer Katie Pollard elected as AAAS fellow

Computational biology pioneer Katie Pollard elected as AAAS fellow
2024-04-18
SAN FRANCISCO—April 18, 2024—The American Association for the Advancement of Science (AAAS), one of the world’s largest general scientific societies, has elected Gladstone Senior Investigator Katie Pollard, PhD, into its new class of AAAS Fellows, a lifetime honor within the scientific community. AAAS recognized Pollard for her “distinguished contributions to the field of computational biology and bioinformatics, particularly her discovery of Human Accelerated Regions, and development of ...

New “window-of-opportunity” clinical trials explore cutting-edge treatments for cancers of the liver, head and neck

2024-04-18
April 18, 2024, TORONTO – A new round of clinical trials supported by the Ontario Institute for Cancer Research (OICR) will harness a unique opportunity to test some of the newest treatment strategies for a range of different cancers. OICR has announced two new clinical trials as part of its Window-of-Opportunity (WOO) Network, which brings together Ontario researchers, clinicians and patients to study the biology of newly diagnosed and recurrent tumours. “‘Window-of-opportunity’ clinical trials take advantage of the two-to-eight-week period between the diagnosis of cancer and the surgery to remove the cancer, at ...

LAST 30 PRESS RELEASES:

Sports injuries sustained during your period might be more severe

World's first successful 2 Tbit/s free-space optical communication using small optical terminals mountable on satellites and HAPS

Can intimate relationships affect your heart? New study says ‘yes’

Scalable and healable gradient textiles for multi‑scenario radiative cooling via bicomponent blow spinning

Research shows informed traders never let a good climate crisis go to waste

Intelligent XGBoost framework enhances asphalt pavement skid resistance assessment

Dual-function biomaterials for postoperative osteosarcoma: Tumor suppression and bone regeneration

New framework reveals where transport emissions concentrate in Singapore

NTP-enhanced lattice oxygen activation in Ce-Co catalysts for low-temperature soot combustion

Synergistic interface engineering in Cu-Zn-Ce catalysts for efficient CO2 hydrogenation to methanol

COVID-19 leaves a lasting mark on the human brain

Scientists use ultrasound to soften and treat cancer tumors without damaging healthy tissue

Community swimming program for Black youth boosts skills, sense of belonging, study finds

Specific depressive symptoms in midlife linked to increased dementia risk

An ‘illuminating’ design sheds light on cholesterol

Who is more likely to get long COVID?

Study showcases resilience and rapid growth of “living rocks”

Naval Research Lab diver earns Office of Naval Research 2025 Sailor of the Year

New Mayo-led study establishes practical definition for rapidly progressive dementia

Fossil fuel industry’s “climate false solutions” reinforce its power and aggravate environmental injustice 

Researchers reveal bias in a widely used measure of algorithm performance

Alcohol causes cancer. A study from IOCB Prague confirms damage to DNA and shows how cells defend against it

Hidden viruses in wastewater treatment may shape public health risks, study finds

Unlock the power of nature: how biomass can transform climate mitigation

Biochar reshapes hidden soil microbes that capture carbon dioxide in farmland

Reducing saturated fat intake shows mortality benefit, but only in high-risk individuals

Manta rays create mobile ecosystems, study finds

Study: Mixed results in using lipoic acid to treat progressive multiple sclerosis

Norbert Holtkamp appointed director of Fermi National Accelerator Laboratory

New agentic AI platform accelerates advanced optics design

[Press-News.org] Adherence to American Cancer Society nutrition and physical activity guidelines among cancer survivors
JAMA Oncology